Dr.Ergo® L-Ergothioneine Food 99.99% Ingredient Powder Water Soluble

Dr.Ergo® L-Ergothioneine is a high-purity functional nutrition ingredient developed for sleep-quality research, nighttime wellness, stress-management, healthy-aging and premium supplement formulations.

With an L-Ergothioneine content of 99.99%, Dr.Ergo® provides B2B customers with a standardized active ingredient for capsules, tablets, powders, gummies, functional jellies, nighttime beverages and other nutritional applications.

L-Ergothioneine, commonly abbreviated as EGT, is a dietary sulfur-containing amino acid derivative found naturally in certain mushrooms and microorganisms. Beyond its established research relevance to oxidative stress and cellular protection, EGT is also being investigated in relation to sleep quality and nighttime recovery.

A randomized, double-blind, placebo-controlled human study evaluated daily intake of 20 mg EGT for four weeks in volunteers reporting high anxiety and sleep complaints. The study examined both subjective questionnaires and objective electroencephalographic measurements.

Results included changes in sleeping-difficulty scores, non-REM sleep structure and waking after sleep onset. These findings provide an early human research basis for EGT in sleep-related product development, but they do not establish EGT as a treatment for insomnia or other sleep disorders.

Dr.Ergo® may therefore be evaluated for formulation concepts related to:

• Nighttime wellness
• Sleep-quality research
• Stress-management nutrition
• Healthy aging
• Daily recovery
• Cognitive and emotional wellness
• Antioxidant and cellular-protection support

Published studies on EGT as a compound should not automatically be described as clinical studies of Dr.Ergo® unless the branded ingredient was specifically used and documented.

Dr.Ergo® may be considered for products developed around nighttime nutrition, daily recovery and healthy sleep routines.

Potential product formats include:

• Nighttime capsules and tablets
• Powder sachets
• Functional jellies
• Gummies
• Nighttime nutrition drinks
• Ready-to-mix powders
• Multi-ingredient healthy-aging formulas

The principal human study used a randomized, placebo-controlled, double-blind, parallel-group design. Volunteers reporting high anxiety and sleep complaints received either 20 mg EGT or placebo daily for four weeks.

The researchers reported changes in:

• Subjective sleeping-difficulty questionnaires
• N1 and N2 stages of non-REM sleep
• Frequency of waking after sleep onset
• Selected serum metabolites
• Potential molecular targets related to sleep regulation

Specifically, EGT intake was associated with increased N2 sleep, decreased N1 sleep and fewer waking episodes after sleep onset in the study population. These results are relevant to sleep-quality research, but they require confirmation through additional independent studies involving larger and more diverse populations.